Assisted Reproduction Centre, European Hospital, Rome, Italy.
Curr Opin Obstet Gynecol. 2011 Dec;23(6):415-21. doi: 10.1097/GCO.0b013e32834cef0c.
The current review aims to provide an overview of the already available and emerging treatment modalities for caesarean scar pregnancy (CSP).
CSP is a type of ectopic gestation associated with a high risk of serious complications. The cause of this condition and the best management are still unclear. However, some medical and surgical treatment modalities have been suggested. The main objectives in the clinical management of CSP should be the prevention of massive blood loss and the conservation of the uterus to maintain further fertility, women's health and quality of life. Current data suggest that expectant management should not be recommended, whereas there are accumulating data suggesting that early diagnosis offers single or combined medical and surgical treatment options avoiding uterine rupture and haemorrhage, thus preserving the uterus and fertility.
No universal treatment guidelines for the management of CSP have been published up to now. The lack of data on the best evidence should encourage any individual case report and further multicentre studies for recommendations establishment.
本文旨在概述剖宫产术后子宫瘢痕妊娠（CSP）的现有和新兴治疗方法。
CSP 是一种与严重并发症风险较高的异位妊娠。这种情况的原因和最佳治疗方法尚不清楚。然而，已经提出了一些医疗和手术治疗方法。CSP 临床管理的主要目标应该是预防大量出血和保留子宫以维持进一步的生育能力、妇女的健康和生活质量。目前的数据表明，不应推荐期待治疗，而越来越多的数据表明，早期诊断可提供单一或联合的医疗和手术治疗选择，避免子宫破裂和出血，从而保留子宫和生育能力。
到目前为止，还没有关于 CSP 管理的通用治疗指南。关于最佳证据的数据不足，应该鼓励任何个案报告和进一步的多中心研究，以制定建议。
